Unknown

Dataset Information

0

Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion.


ABSTRACT: Muscarinic receptors (CHRM) are overexpressed in colon cancer. To explore a role for muscarinic receptor signaling in colon cancer metastasis, we used human H508 and HT29 colon cancer cells that coexpress epidermal growth factor (ERBB) and CHRM3 receptors. In a wound closure model, following 8-h incubation of H508 cells with 100 ?M ACh we observed a threefold increase in cell migration indistinguishable from the actions of epidermal growth factor (EGF). Atropine blocked the actions of ACh but not of EGF. In SNU-C4 colon cancer cells that express ERBB but not CHRM, EGF caused a threefold increase in migration; ACh had no effect. ACh-induced cell migration was attenuated by chemical inhibitors of ERBB1 activation, by anti-ERBB1 antibody, and by inhibitors of ERK and phosphatidylinositol 3-kinase (PI3K) signaling. Consistent with matrix metalloproteinase-7 (MMP7)-mediated release of an ERBB1 ligand, heparin binding epidermal growth factor-like growth factor (HBEGF), ACh-induced migration was inhibited by an MMP inhibitor and by anti-MMP7 and -HBEGF antibodies. ACh-induced cell migration was blocked by inhibiting RhoA and ROCK, key proteins that interact with the actin cytoskeleton. ACh-induced RhoA activation was attenuated by agents that inhibit ERBB1, ERK, and PI3K activation. Collectively, these findings indicate that ACh-induced cell migration is mediated by MMP7-mediated release of HBEGF, an ERBB ligand that activates ERBB1 and downstream ERK and PI3K signaling. In a cell invasion model, ACh-induced HT29 cell invasion was blocked by atropine. In concert with previous observations, these findings indicate that muscarinic receptor signaling plays a key role in colon cancer cell proliferation, survival, migration, and invasion.

SUBMITTER: Belo A 

PROVIDER: S-EPMC3094147 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion.

Belo Angelica A   Cheng Kunrong K   Chahdi Ahmed A   Shant Jasleen J   Xie Guofeng G   Khurana Sandeep S   Raufman Jean-Pierre JP  

American journal of physiology. Gastrointestinal and liver physiology 20110127 5


Muscarinic receptors (CHRM) are overexpressed in colon cancer. To explore a role for muscarinic receptor signaling in colon cancer metastasis, we used human H508 and HT29 colon cancer cells that coexpress epidermal growth factor (ERBB) and CHRM3 receptors. In a wound closure model, following 8-h incubation of H508 cells with 100 μM ACh we observed a threefold increase in cell migration indistinguishable from the actions of epidermal growth factor (EGF). Atropine blocked the actions of ACh but no  ...[more]

Similar Datasets

| S-EPMC5650067 | biostudies-literature
| S-EPMC3643652 | biostudies-literature
| S-EPMC7817160 | biostudies-literature
| S-EPMC2910705 | biostudies-literature
| S-EPMC10571583 | biostudies-literature
| S-EPMC6115746 | biostudies-literature
| S-EPMC4151735 | biostudies-literature
| S-EPMC8946220 | biostudies-literature
| S-EPMC5251210 | biostudies-literature
| S-EPMC3348253 | biostudies-other